[HTML][HTML] Recent advancements in microfluidic-based biosensors for detection of genes and proteins: applications and techniques

S Siavashy, M Soltani, S Rahimi, M Hosseinali… - … and Bioelectronics: X, 2024 - Elsevier
This article has tried to provide an overview of the most sophisticated microfluidic biosensors
for identifying nucleic acids and proteins at the site of treatment. Microfluidics, which also …

Advances in prostate cancer biomarkers and probes

K Li, Q Wang, X Tang, OU Akakuru, R Li… - Cyborg and Bionic …, 2024 - spj.science.org
Prostate cancer is one of the most prevalent malignant tumors in men worldwide, and early
diagnosis is essential to improve patient survival. This review provides a comprehensive …

Sex hormone-binding globulin and its critical role in prostate cancer: A comprehensive review

AG Mukherjee, AV Gopalakrishnan - The Journal of Steroid Biochemistry …, 2024 - Elsevier
Prostate cancer (PC) is a common and widespread cancer that affects men globally. A
complicated interaction of hormonal variables influences its development. Sex hormone …

Analysis of genetic biomarkers, polymorphisms in ADME-related genes and their impact on pharmacotherapy for prostate cancer

K Rehman, Z Iqbal, D Zhiqin, H Ayub, N Saba… - Cancer Cell …, 2023 - Springer
Prostate cancer (PCa) is a non-cutaneous malignancy in males with wide variation in
incidence rates across the globe. It is the second most reported cause of cancer death. Its …

Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine

F Marino, A Totaro, C Gandi, R Bientinesi… - Prostate cancer and …, 2023 - nature.com
Background The goal of precision medicine in prostate cancer (PCa) is to individualize the
treatment according to the patient's germline mutation status. PCa has a very high rate of …

Non-coding RNAs in tuberculosis epidemiology: Platforms and approaches for investigating the genome's dark matter

A Almatroudi - International Journal of Molecular Sciences, 2022 - mdpi.com
A growing amount of information about the different types, functions, and roles played by
non-coding RNAs (ncRNAs) is becoming available, as more and more research is done …

Genomic and phenotypic biomarkers for precision medicine guidance in advanced prostate cancer

F Davoudi, A Moradi, TM Becker, JG Lock… - … Treatment Options in …, 2023 - Springer
Opinion statement Prostate cancer (PCa) is the second most diagnosed malignant
neoplasm and is one of the leading causes of cancer-related death in men worldwide …

Correlation between genomic variants and worldwide epidemiology of prostate cancer

GM Vieira, LPA Gellen, DF da Veiga Borges Leal… - Genes, 2022 - mdpi.com
Prostate cancer (PCa) incidence and mortality vary across territories and populations. This
can be explained by the genetic factor of this disease. This article aims to correlate the …

MicroRNAs as biomarkers for early diagnosis, targeting and prognosis of prostate cancer

A Azani, SP Omran, H Ghasrsaz, A Idani… - … -Research and Practice, 2023 - Elsevier
Globally, prostate cancer (PC) is leading cause of cancer-related mortality in men
worldwide. Despite significant advances in the treatment and management of this disease …

The role of genetic polymorphisms in the diagnosis and management of prostate cancer: an update

L DELL'ATTI, G Aguiari - Anticancer Research, 2023 - ar.iiarjournals.org
Prostate cancer (PCa) is the most common non-cutaneous tumor among men worldwide
and, if diagnosed late, it exhibits a high mortality representing the sixth most lethal tumor in …